SLN Stock Earnings: Silence Therapeutics reported Q2 2024 results

InvestorPlace Earnings is a project that uses data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways, including earnings per share and revenue, as well as how a company measures up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers about the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at [email protected].